Abstract
Over the last years significant advances have been made in the area of drug delivery with the development of modified-release (MR) dosage forms. The present review is divided into two parts, one dealing with technologies for the design of modified-release drug delivery tablets and the other with the use of synthetic and natural polymers that are capable of controlling drug release.
Keywords: Matrix tablets, modified-release, controlled-release, extended-release, multilayer, coating, zero-order, natural polymers
Mini-Reviews in Medicinal Chemistry
Title: Polymeric Materials and Formulation Technologies for Modified-Release Tablet Development
Volume: 9 Issue: 13
Author(s): J. Zarate, M. Igartua, R. M. Hernandez and J. L. Pedraz
Affiliation:
Keywords: Matrix tablets, modified-release, controlled-release, extended-release, multilayer, coating, zero-order, natural polymers
Abstract: Over the last years significant advances have been made in the area of drug delivery with the development of modified-release (MR) dosage forms. The present review is divided into two parts, one dealing with technologies for the design of modified-release drug delivery tablets and the other with the use of synthetic and natural polymers that are capable of controlling drug release.
Export Options
About this article
Cite this article as:
Zarate J., Igartua M., Hernandez M. R. and Pedraz L. J., Polymeric Materials and Formulation Technologies for Modified-Release Tablet Development, Mini-Reviews in Medicinal Chemistry 2009; 9 (13) . https://dx.doi.org/10.2174/138955709790361539
DOI https://dx.doi.org/10.2174/138955709790361539 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhibition of Opioid Receptor Mediated G-Protein Activity After Chronic Administration of Kynurenic Acid and its Derivative without Direct Binding to Opioid Receptors
CNS & Neurological Disorders - Drug Targets Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
Current Alzheimer Research Pharmacokinetics and Metabolic Drug Interactions
Current Clinical Pharmacology 2-Arylindoles: A Privileged Molecular Scaffold with Potent, Broad-Ranging Pharmacological Activity
Current Medicinal Chemistry Reverse Iontophoretic Extraction of Gabapentin: A Mechanistic Study
Current Drug Delivery Galanin: A Novel Therapeutic Target for Depression, Anxiety Disorders and Drug Addiction?
CNS & Neurological Disorders - Drug Targets Mind-Body Practices and the Adolescent Brain: Clinical Neuroimaging Studies
Adolescent Psychiatry Genome-wide Membrane Protein Structure Prediction
Current Genomics Mechanisms of Neuronal Injury and Death in HIV-1 Associated Dementia
Current HIV Research The Role and Impact of SNPs in Pharmacogenomics and Personalized Medicine
Current Drug Metabolism Functional Food with Some Health Benefits, So Called Superfood: A Review
Current Nutrition & Food Science Gastrointestinal Immune System and Brain Dialogue Implicated in Neuroinflammatory and Neurodegenerative Diseases
Current Molecular Medicine ABC Transporters in the CNS – An Inventory
Current Pharmaceutical Biotechnology Recent Patents and Discovery of Anti-inflammatory Agents from Marine Source
Recent Patents on Inflammation & Allergy Drug Discovery Novel 3-{4-[2-Amino-4-(Substitutedphenyl)-2H-[1, 3] Oxazin/Thiazin-6-Yl} -2-Phenyl-3H-Quinazolin-4-One Derivatives as Enhancer of GABA Mediated Inhibition: Synthesis, Molecular Modeling and Pharmacological Studies
Letters in Drug Design & Discovery Patent Selections:
Recent Patents on Regenerative Medicine Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Current Pharmaceutical Design Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease
CNS & Neurological Disorders - Drug Targets Activity-Dependent Release of Adenosine: A Critical Re-Evaluation of Mechanism
Current Neuropharmacology Subject Index To Volume 9
Current Medicinal Chemistry